Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Class I Recall Issued for Prescription Hormone
10/04/2019
The FDA has issued a Class I recall for a prescription parathyroid hormone used with calcium and vitamin D to control hypocalcemia in people with hypoparathyroidism. 
The FDA has issued a Class I recall for a prescription parathyroid hormone used with calcium and vitamin D to control hypocalcemia in people with hypoparathyroidism. 
The FDA has issued a Class I...
10/04/2019
Pharmacy Learning Network

Advertisement

News
Anesthetic Jelly Recalled
10/04/2019
Over 10,000 tubes of a prescription local anesthetic agent used to control pain in procedures involving the urethra, to treat painful urethritis, or as an anesthetic lubricant for endotracheal intubation are being recalled.
Over 10,000 tubes of a prescription local anesthetic agent used to control pain in procedures involving the urethra, to treat painful urethritis, or as an anesthetic lubricant for endotracheal intubation are being recalled.
Over 10,000 tubes of a...
10/04/2019
Pharmacy Learning Network
News
ATS, IDSA Update Guidelines on Community-Acquired Pneumonia
10/02/2019
The American Thoracic Society and the Infectious Diseases Society of America have updated their guidelines from 2007 on the management of adults with community-acquired pneumonia.
The American Thoracic Society and the Infectious Diseases Society of America have updated their guidelines from 2007 on the management of adults with community-acquired pneumonia.
The American Thoracic Society...
10/02/2019
Pharmacy Learning Network
News
Walmart Becomes Latest U.S. Retailer to Pull Heartburn Drug Zantac
10/02/2019
Walmart became one of the last remaining major US retailers to suspend the sale of over-the-counter heartburn medication containing ranitidine.
Walmart became one of the last remaining major US retailers to suspend the sale of over-the-counter heartburn medication containing ranitidine.
Walmart became one of the last...
10/02/2019
Pharmacy Learning Network

Advertisement

News
AstraZeneca Combo Lung Disease Therapy Fails to Win FDA Approval
10/01/2019
According to AstraZeneca, the FDA has declined to approve its combination therapy used for the treatment of smoker's lung.
According to AstraZeneca, the FDA has declined to approve its combination therapy used for the treatment of smoker's lung.
According to AstraZeneca, the...
10/01/2019
Pharmacy Learning Network
News
U.S. FDA Issues Warning Letters to Websites Selling Illegal Opioids
09/30/2019
The FDA and DEA have issued joint warning letters to four online networks for illegally marketing unapproved and misbranded versions of opioid medicines.
The FDA and DEA have issued joint warning letters to four online networks for illegally marketing unapproved and misbranded versions of opioid medicines.
The FDA and DEA have issued...
09/30/2019
Pharmacy Learning Network
News
CVS Suspends Sales of Zantac Brand and Generic Heartburn Drug During Safety Review
09/30/2019
According to CVS, the company will discontinue sales of the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products.
According to CVS, the company will discontinue sales of the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products.
According to CVS, the company...
09/30/2019
Pharmacy Learning Network

Advertisement

News
U.S. CDC Recommends Against Using Vapes With Marijuana Ingredient
09/27/2019
According to US public health officials, people should stop using e-cigarettes, especially those with marijuana ingredient tetrahydrocannabinol.
According to US public health officials, people should stop using e-cigarettes, especially those with marijuana ingredient tetrahydrocannabinol.
According to US public health...
09/27/2019
Pharmacy Learning Network
News
Mylan to Pay $30 Mln U.S. SEC Fine Related to EpiPen Overcharge Probe
09/27/2019
Mylan NV has agreed to pay a $30 million fine to settle U.S. Securities and Exchange Commission charges.
Mylan NV has agreed to pay a $30 million fine to settle U.S. Securities and Exchange Commission charges.
Mylan NV has agreed to pay a $30...
09/27/2019
Pharmacy Learning Network
News
Epilepsy Drug Recalled
09/27/2019
A prescription medication used to treat people with epilepsy, distributed throughout the United States and Puerto Rico, is being recalled.
A prescription medication used to treat people with epilepsy, distributed throughout the United States and Puerto Rico, is being recalled.
A prescription medication used...
09/27/2019
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use